Popular diabetes and weight-loss drug may reduce risk of Alzheimer’s disease Post author: Post published:October 24, 2024 Post category:uncategorized Post comments:0 Comments Researchers have found that semaglutide may lower the risk of Alzheimer’s disease in people with type 2 diabetes (T2D). You Might Also Like Comparative study on preventative SMA therapies shows mixed outcomes June 25, 2024 Abelacimab significantly reduces bleeding risk in atrial fibrillation patients with stroke risk November 13, 2023 Just Diagnosed with Type 1 Diabetes? This Drug Could Protect Your Insulin Production May 20, 2024 Leave a Reply Cancel replyYou must be logged in to post a comment.
Abelacimab significantly reduces bleeding risk in atrial fibrillation patients with stroke risk November 13, 2023